BRANFORD, Conn., June 5 /PRNewswire-FirstCall/ -- Neurogen Corporation , a drug discovery and development company, announced today that William H. Koster, President and CEO, will present a Company overview and pipeline update at the Pacific Growth Equities Life Sciences Growth Conference on Monday, June 12 at 3:30 p.m. PT.
This presentation is being webcast live from the InterContinental Mark Hopkins Hotel in San Francisco and may be accessed through the investor relations section of the Company's web site: http://www.neurogen.com . The webcast will be also be archived in this section under "Events Calendar & Past Events Replay."
About Neurogen
Neurogen Corporation targets new small molecule drugs to improve the lives of patients suffering from disorders with significant unmet medical need, including insomnia, pain, depression, obesity, and inflammation. Neurogen has generated a portfolio of compelling new drug candidates through its Accelerated Intelligent Drug Discovery (AIDD(TM)) system, its expertise in cellular functional assays, and its depth in medicinal chemistry. Neurogen conducts its research and development independently and, when advantageous, collaborates with world-class pharmaceutical companies to obtain additional resources and to access complementary expertise.
Neurogen CorporationCONTACT: Elaine Grimsell Dodge of Neurogen Corp., +1-203-315-4615,edodge@nrgn.com
Web site: http://www.neurogen.com/
